<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>BELLADONNA AND OPIUM- atropa belladonna and opium suppository </strong><br>Paddock Laboratories, LLC<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>BELLADONNA &amp; OPIUM<br>RECTAL SUPPOSITORIES</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="DLDE"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<p class="First"><span class="Bold">CII</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Each belladonna and opium suppository contains (in a water-soluble base consisting of Polyethylene Glycol 400, 1450, 8000 and Polysorbate 60):</p>
<div class="Section" data-sectionCode="42229-5">
<a name="section-2.1"></a><p></p>
<h2>Belladonna (16.2 mg) and Opium (30 mg):</h2>
<p class="First">Powdered opium 30 mg (Warning: May be habit forming.) and powdered belladonna extract 16.2 mg.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-2.2"></a><p></p>
<h2>Belladonna (16.2 mg) and Opium (60 mg):</h2>
<p class="First">Powdered opium 60 mg (Warning: May be habit forming.) and powdered belladonna extract 16.2 mg.</p>
<p>This drug <span class="product-label-link" type="condition" conceptid="436583" conceptname="Fall">falls</span> into the pharmacological/therapeutic class of narcotic analgesic/antispasmotic agents.</p>
<p>The pharmacologically active principles present in the belladonna extract component of belladonna and opium suppositories are:</p>
<table class="Noautorules" width="100%">
<col align="center" valign="bottom" width="100%">
<tbody class="Headless">
<tr><td align="center"><img alt="Chemical Structure 1" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8301e76b-134a-43d2-a7dc-c600ccf2695c&amp;name=belladonna-01.jpg"></td></tr>
<tr><td align="center">
<span class="Bold">Established Name</span>: Atropine <br><span class="Bold">Chemical Name</span>: dl Tropyl Tropate</td></tr>
<tr><td align="center"><img alt="Chemical Structure 2" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8301e76b-134a-43d2-a7dc-c600ccf2695c&amp;name=belladonna-02.jpg"></td></tr>
<tr><td align="center">
<span class="Bold">Established Name:</span> Scopolamine <br><span class="Bold">Chemical Name</span>: dl Scopolamine</td></tr>
</tbody>
</table>
<p>Opium contains more than twenty alkaloids, the principle ones being morphine (10%), narcotine (6%), papaverine (1%) and codeine (0.5%). The major pharmacologically active principle of the powdered opium component of belladonna and opium suppositories, however, is:</p>
<table class="Noautorules" width="100%">
<col align="center" valign="bottom" width="100%">
<tbody class="Headless">
<tr><td align="center"><img alt="Chemical Structure 3" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8301e76b-134a-43d2-a7dc-c600ccf2695c&amp;name=belladonna-03.jpg"></td></tr>
<tr><td align="center">
<span class="Bold">Name</span>: Morphine <br><span class="Bold">Chemical Name</span>: <br>7, 8-Didehydro-4, 5-epoxy-<br>17-Methyl-morphinan-3, 6-diol</td></tr>
</tbody>
</table>
</div>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Through its parasympatholytic action, atropine relaxes smooth muscle resulting from parasympathetic stimulation. It is the dl isomer of l-hyoscyamine and therefore exhibits the same clinical effects. It is, however, approximately one-half as active peripherally as lhyoscyamine, the latter being the major active plant alkaloid. The dl isomer atropine is formed during the process of isolation of the belladonna extract.<span class="Sup">1</span></p>
<p>Morphine, the major active principle of powdered opium, is responsible for the action of powdered opium although the other alkaloids present also contribute to it. The sedative and analgesic action of morphine, the effect desired by inclusion in belladonna and opium suppositories of powdered opium, are thought to be due to the depressant effect on the cerebral cortex, hypothalamus and medullary centers. In large doses, the opiates and their analogs also exhibit synaptic conduction in the spinothalamic tracts, depress the function of the reticular formation, the lemniscus and the thalamic relays, and inhibit spinal synaptic reflexes: but these inhibitor actions should not be elicited with therapeutic doses of the drug. Moderate doses of powdered opium should not alter the electroencephalogram.</p>
<p>The action of morphine consists mainly of a descending <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> of the central nervous system. It exerts its analgesic action by increasing the <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> threshold or the magnitude of stimulus required to evoke <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> and by dulling the sensibility or reaction to <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>. In addition to its action in abolishing <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>, morphine induces a sense of well-being (<span class="product-label-link" type="condition" conceptid="4142453" conceptname="Feeling high">euphoria</span>) facilitating certain mental processes while retarding others. Upon absorption of morphine, oxidative dealkylation to produce nor-compounds appears to be the first step in the reaction sequence which imparts <span class="product-label-link" type="condition" conceptid="4242687" conceptname="No sensitivity to pain">analgesia</span>. Morphine is conjugated in the liver to form the 3-glucuronide which passes into the bile and is reabsorbed and excreted in the urine. The atropine effect of the belladonna extract serves to eliminate morphine induced smooth <span class="product-label-link" type="condition" conceptid="75635" conceptname="Cramp">muscle spasm</span> without affecting the sedative analgesic action of powdered opium.<span class="Sup">2</span></p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Belladonna and opium suppositories are used for relief of moderate to severe <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> associated with ureteral spasm not responsive to non-narcotic analgesics and to space intervals between injections of opiates.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Do not use belladonna and opium suppositories in patients suffering from <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>, severe hepatic or <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span>, bronchial <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>, narcotic idiosyncrasies, <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">respiratory depression</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsive disorders</span>, acute <span class="product-label-link" type="condition" conceptid="4218106" conceptname="Alcoholism">alcoholism</span>, <span class="product-label-link" type="condition" conceptid="377830" conceptname="Alcohol withdrawal delirium">delirium tremens</span> and <span class="product-label-link" type="condition" conceptid="4273560" conceptname="Premature labor">premature labor</span>.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">True addiction may result from opium usage. These preparations are not recommended for use in children.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First">Administer with caution to persons with a known idiosyncrasy to atropine or to atropinelike compounds; to persons known to be sensitive to or addicted to morphine or morphinelike drugs; to persons with cardiac disease, incipient <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span> or <span class="product-label-link" type="condition" conceptid="198803" conceptname="Benign prostatic hyperplasia">prostatic hypertrophy</span>. Caution should be used in the administration of this drug to elderly and debilitated patients and patients with <span class="product-label-link" type="condition" conceptid="4154803" conceptname="Raised intracranial pressure">increased intracranial pressure</span>, toxic <span class="product-label-link" type="condition" conceptid="436073" conceptname="Psychotic disorder">psychosis</span> and <span class="product-label-link" type="condition" conceptid="4182596" conceptname="Myxedema">myxedema</span>.</p>
<div class="Section" data-sectionCode="42228-7">
<a name="section-7.1"></a><p></p>
<h2>Pregnancy Category C</h2>
<p class="First">Animal studies have not been conducted with belladonna and opium suppositories. It is also not known whether belladonna and opium suppositories can affect reproductive capacity. The active principles of belladonna and opium suppositories, atropine and morphine, are known to enter the fetal circulation. Regular use of opium alkaloids during pregnancy has resulted in addiction of the fetus leading to withdrawal symptoms in the neonate. Belladonna and opium suppositories therefore should be used by a pregnant woman with caution and only when clearly indicated.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-7.2"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when belladonna and opium suppositories are administered to a nursing woman.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Belladonna may cause <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">dry mouth</span>, <span class="product-label-link" type="condition" conceptid="192450" conceptname="Retention of urine">urinary retention</span>, <span class="product-label-link" type="condition" conceptid="4260194" conceptname="Photophobia">photophobia</span>, rapid pulse, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span> and <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>. Opium usage may result in <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> or <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>. Pruritis and <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span> may occasionally occur.</p>
</div>
<div class="Section" data-sectionCode="42227-9">
<a name="section-9"></a><p></p>
<h1>DRUG ABUSE AND <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">DEPENDENCE</span></h1>
<p class="First">Because of their content of opium, belladonna and opium suppositories are considered as Schedule II drugs by the Drug Enforcement Administration. No data exists on chronic abuse effects or <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">dependence</span> characteristics of belladonna and opium suppositories.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-10"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">As with morphine and related narcotics, overdosage is characterized by <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">respiratory depression</span>, pinpoint pupils and <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span>. <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">Respiratory depression</span> may be reversed by intravenous administration of naloxone hydrochloride. In addition, supportive measures such as oxygenation, intravenous fluids and vasopressors should be used as indicated. As with atropine derivatives, hot, dry, <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushed skin</span>; <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">dry mouth</span> and <span class="product-label-link" type="condition" conceptid="4260205" conceptname="Hyperpyrexia">hyperpyrexia</span> may occur.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-11"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="section-11.1"></a><p></p>
<h2>Adults:</h2>
<p class="First">One belladonna and opium suppository rectally once or twice daily, not to exceed four doses daily or as recommended by the physician. Moisten finger and suppository with water before inserting. Absorption is dependent on body hydration and not on body temperature.</p>
<p><span class="Bold">Not recommended for use in children 12 years of age and under.</span></p>
</div>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="section-12"></a><p></p>
<p class="First">Store at room temperature. DO NOT REFRIGERATE. PROTECT FROM MOISTURE DURING STORAGE.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-13"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Belladonna (16.2 mg) and Opium (30 mg) suppositories are easy to open, color-coded and available in cartons of 12's.</p>
<dl>
<dt> </dt>
<dd>12's     NDC 0574-7045-12</dd>
</dl>
<p>Belladonna (16.2 mg) and Opium (60 mg) suppositories are easy to open, color coded and available in cartons of 12's.</p>
<dl>
<dt> </dt>
<dd>12's     NDC 0574-7040-12</dd>
</dl>
<p>Schedule II controlled substances-DEA order required.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-14"></a><p></p>
<h1>Caution:</h1>
<p class="First">Federal law prohibits transfer of this drug to any person other than the patient for whom it was prescribed.</p>
</div>
<div class="Section" data-sectionCode="34093-5">
<a name="section-15"></a><p></p>
<p class="First">1. Gilman, A.G., Goodman, L.S. &amp; Gilman, A 6th Edition, <span class="Italics">The Pharmacological Basis of Therapeutics</span>, MacMillan Pub. Co., NY 1980, pp. 121-127</p>
<p>2. Ibid, pp. 494-513</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-16"></a><p></p>
<p class="First">Manufactured by:<br>Paddock Laboratories, Inc.<br>Minneapolis, MN 55427</p>
<p>(07-05)</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-17"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 16.2 mg/30 mg Suppository Label</h1>
<p class="First"><span class="Bold">BELLADONNA AND OPIUM<br>16.2 mg/30 mg Suppository<br>(01)10305747045121</span></p>
<p><span class="Bold">CII</span></p>
<p><span class="Bold">Paddock Laboratories, Inc.<br>Minneapolis, MN 55427</span></p>
<div class="Figure"><img alt="PRINCIPAL DISPLAY PANEL - 16.2 mg/30 mg Suppository Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8301e76b-134a-43d2-a7dc-c600ccf2695c&amp;name=belladonna-04.jpg"></div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-18"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 16.2 mg/60 mg Suppository Label</h1>
<p class="First"><span class="Bold">Belladonna &amp; Opium<br>16.2 mg/60 mg Suppository<br>(01)10305747040126</span></p>
<p><span class="Bold">CII</span></p>
<p><span class="Bold">Paddock Laboratories, Inc.<br>Minneapolis, MN 55427</span></p>
<div class="Figure"><img alt="PRINCIPAL DISPLAY PANEL - 16.2 mg/60 mg Suppository Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8301e76b-134a-43d2-a7dc-c600ccf2695c&amp;name=belladonna-05.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>BELLADONNA AND OPIUM 		
					</strong><br><span class="contentTableReg">atropa belladonna and opium suppository</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0574-7040</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">RECTAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">CII    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>ATROPA BELLADONNA</strong> (ATROPA BELLADONNA) </td>
<td class="formItem">ATROPA BELLADONNA</td>
<td class="formItem">16.2 mg</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>OPIUM</strong> (OPIUM) </td>
<td class="formItem">OPIUM</td>
<td class="formItem">30 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POLYETHYLENE GLYCOL 400</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYETHYLENE GLYCOL 8000</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POLYETHYLENE GLYCOL 1450</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYSORBATE 60</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE</td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">BULLET</td>
<td class="formLabel">Size</td>
<td class="formItem">35mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0574-7040-12</td>
<td class="formItem">12  in 1 BOX</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">1  in 1 PACKET</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">UNAPPROVED DRUG OTHER</td>
<td class="formItem"></td>
<td class="formItem">04/22/1997</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>BELLADONNA AND OPIUM 		
					</strong><br><span class="contentTableReg">atropa belladonna and opium suppository</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0574-7045</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">RECTAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">CII    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>ATROPA BELLADONNA</strong> (ATROPA BELLADONNA) </td>
<td class="formItem">ATROPA BELLADONNA</td>
<td class="formItem">16.2 mg</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>OPIUM</strong> (OPIUM) </td>
<td class="formItem">OPIUM</td>
<td class="formItem">60 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POLYETHYLENE GLYCOL 400</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYETHYLENE GLYCOL 8000</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POLYETHYLENE GLYCOL 1450</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYSORBATE 60</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE</td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">BULLET</td>
<td class="formLabel">Size</td>
<td class="formItem">35mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0574-7045-12</td>
<td class="formItem">12  in 1 BOX</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">1  in 1 PACKET</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">UNAPPROVED DRUG OTHER</td>
<td class="formItem"></td>
<td class="formItem">05/01/1994</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Paddock Laboratories, LLC
							(967694121)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Paddock Laboratories, LLC</td>
<td class="formItem"></td>
<td class="formItem">967694121</td>
<td class="formItem">MANUFACTURE(0574-7040, 0574-7045)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 8/2012<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>e1e6a959-3d6d-46e6-b0fe-c5d6166ef440</div>
<div>Set id: 8301e76b-134a-43d2-a7dc-c600ccf2695c</div>
<div>Version: 1</div>
<div>Effective Time: 20120817</div>
</div>
</div> <div class="DistributorName">Paddock Laboratories, LLC</div></p>
</body></html>
